Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse ; volume:11 ; number:1 ; day:11 ; month:1 ; year:2021 ; pages:1-12 ; date:12.2021
Scientific reports ; 11, Heft 1 (11.1.2021), 1-12, 12.2021
- Creator
-
Sanchez-Spitman, A. B.
Swen, J. J.
Dezentjé, V. O.
Moes, D. J. A. R.
Gelderblom, H.
Guchelaar, H. J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-79972-x
- URN
-
urn:nbn:de:101:1-2021020612405029485130
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sanchez-Spitman, A. B.
- Swen, J. J.
- Dezentjé, V. O.
- Moes, D. J. A. R.
- Gelderblom, H.
- Guchelaar, H. J.
- SpringerLink (Online service)
Other Objects (12)
Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study
Genetic variation in drug metabolism and nuclear receptor signaling influence tamoxifen outcome in early breast cancer
CYP2D6 genotypes, endoxifen levels, and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer
Predicting nicotine metabolism across ancestries using genotypes
AFF3 upregulation mediates tamoxifen resistance in breast cancers
Sox2 promotes tamoxifen resistance in breast cancer cells
Tamoxifen
Overexpression of COL11A1 confers tamoxifen resistance in breast cancer
Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex
Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study
Genetic variation in drug metabolism and nuclear receptor signaling influence tamoxifen outcome in early breast cancer
CYP2D6 genotypes, endoxifen levels, and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer
Predicting nicotine metabolism across ancestries using genotypes
AFF3 upregulation mediates tamoxifen resistance in breast cancers
Sox2 promotes tamoxifen resistance in breast cancer cells
Tamoxifen
Overexpression of COL11A1 confers tamoxifen resistance in breast cancer
Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex
Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study
Genetic variation in drug metabolism and nuclear receptor signaling influence tamoxifen outcome in early breast cancer
CYP2D6 genotypes, endoxifen levels, and disease recurrence in 224 Filipino and Vietnamese women receiving adjuvant tamoxifen for operable breast cancer
Predicting nicotine metabolism across ancestries using genotypes
AFF3 upregulation mediates tamoxifen resistance in breast cancers
Sox2 promotes tamoxifen resistance in breast cancer cells
Tamoxifen
Overexpression of COL11A1 confers tamoxifen resistance in breast cancer